Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 0 | 0 | 420 | 2,100 | 1,372 |
| Cost of Goods | N/A | N/A | 11 | 1,774 | 775 |
| Gross Profit | N/A | 0 | 409 | 326 | 597 |
| Operating Expenses | 11,683 | 10,251 | 14,989 | 27,072 | 32,286 |
| Operating Income | -11,683 | -10,251 | -14,569 | -25,972 | -30,914 |
| Interest Expense | 1,474 | 1,577 | 1,447 | 2,207 | 2,035 |
| Other Income | -1,298 | -1,015 | 45,089 | 68 | 8 |
| Pre-tax Income | -14,455 | -12,843 | 29,073 | -28,111 | -32,941 |
| Net Income Continuous | -14,455 | -12,843 | 29,073 | -28,111 | -32,941 |
| Net Income | $-14,455 | $-12,843 | $29,073 | $-28,111 | $-32,941 |
| EPS Basic Total Ops | -6.99 | -7.77 | 19.39 | -18.92 | -22.18 |
| EPS Basic Continuous Ops | -6.99 | -7.76 | 19.39 | -18.92 | -22.18 |
| EPS Diluted Total Ops | -6.99 | -7.63 | 19.25 | -18.92 | -22.18 |
| EPS Diluted Continuous Ops | -6.99 | -7.62 | 19.25 | -18.92 | -22.18 |
| EBITDA(a) | $-11,277 | $-9,876 | $-14,159 | $-25,384 | $-30,325 |